These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 29024868)

  • 1. Introduction of non-invasive prenatal testing as a first-tier aneuploidy screening test: A survey among Dutch midwives about their role as counsellors.
    Martin L; Gitsels-van der Wal JT; de Boer MA; Vanstone M; Henneman L
    Midwifery; 2018 Jan; 56():1-8. PubMed ID: 29024868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uptake of fetal aneuploidy screening after the introduction of the non-invasive prenatal test: A national population-based register study.
    van der Meij KRM; de Groot-van Mooren M; Carbo EWS; Pieters MJ; Rodenburg W; Sistermans EA; Cornel MC; Henneman L;
    Acta Obstet Gynecol Scand; 2021 Jul; 100(7):1265-1272. PubMed ID: 33465829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knowledge and future preference of Chinese women in a major public hospital in Hong Kong after undergoing non-invasive prenatal testing for positive aneuploidy screening: a questionnaire survey.
    Kou KO; Poon CF; Tse WC; Mak SL; Leung KY
    BMC Pregnancy Childbirth; 2015 Sep; 15():199. PubMed ID: 26330276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TRIDENT-2: National Implementation of Genome-wide Non-invasive Prenatal Testing as a First-Tier Screening Test in the Netherlands.
    van der Meij KRM; Sistermans EA; Macville MVE; Stevens SJC; Bax CJ; Bekker MN; Bilardo CM; Boon EMJ; Boter M; Diderich KEM; de Die-Smulders CEM; Duin LK; Faas BHW; Feenstra I; Haak MC; Hoffer MJV; den Hollander NS; Hollink IHIM; Jehee FS; Knapen MFCM; Kooper AJA; van Langen IM; Lichtenbelt KD; Linskens IH; van Maarle MC; Oepkes D; Pieters MJ; Schuring-Blom GH; Sikkel E; Sikkema-Raddatz B; Smeets DFCM; Srebniak MI; Suijkerbuijk RF; Tan-Sindhunata GM; van der Ven AJEM; van Zelderen-Bhola SL; Henneman L; Galjaard RH; Van Opstal D; Weiss MM;
    Am J Hum Genet; 2019 Dec; 105(6):1091-1101. PubMed ID: 31708118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changing to NIPT as a first-tier screening test and future perspectives: opinions of health professionals.
    Tamminga S; van Schendel RV; Rommers W; Bilardo CM; Pajkrt E; Dondorp WJ; van Maarle M; Cornel MC; Henneman L
    Prenat Diagn; 2015 Dec; 35(13):1316-23. PubMed ID: 26411372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The consequences of implementing non-invasive prenatal testing in Dutch national health care: a cost-effectiveness analysis.
    Beulen L; Grutters JP; Faas BH; Feenstra I; van Vugt JM; Bekker MN
    Eur J Obstet Gynecol Reprod Biol; 2014 Nov; 182():53-61. PubMed ID: 25238658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How do the trends in the prenatal diagnosis of aneuploidy change after a non-invasive prenatal test becomes available? A Japanese single center study.
    Hasegawa J; Nakamura M; Sekizawa A
    J Med Ultrason (2001); 2015 Apr; 42(2):195-8. PubMed ID: 26576572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Limits to the scope of non-invasive prenatal testing (NIPT): an analysis of the international ethical framework for prenatal screening and an interview study with Dutch professionals.
    Kater-Kuipers A; Bunnik EM; de Beaufort ID; Galjaard RJH
    BMC Pregnancy Childbirth; 2018 Oct; 18(1):409. PubMed ID: 30340550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prenatal screening for fetal aneuploidy in singleton pregnancies.
    Chitayat D; Langlois S; Douglas Wilson R; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient experience with non-invasive prenatal testing (NIPT) as a primary screen for aneuploidy in the Netherlands.
    Kristalijn SA; White K; Eerbeek D; Kostenko E; Grati FR; Bilardo CM
    BMC Pregnancy Childbirth; 2022 Oct; 22(1):782. PubMed ID: 36266611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and evaluation of training resources to prepare health professionals for counselling pregnant women about non-invasive prenatal testing for Down syndrome: a mixed methods study.
    Oxenford K; Daley R; Lewis C; Hill M; Chitty LS
    BMC Pregnancy Childbirth; 2017 Apr; 17(1):132. PubMed ID: 28449648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementing non-invasive prenatal testing for aneuploidy in a national healthcare system: global challenges and national solutions.
    van Schendel RV; van El CG; Pajkrt E; Henneman L; Cornel MC
    BMC Health Serv Res; 2017 Sep; 17(1):670. PubMed ID: 28927451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nationwide implementation of the non-invasive prenatal test: Evaluation of a blended learning program for counselors.
    Martin L; Gitsels-van der Wal JT; Bax CJ; Pieters MJ; Reijerink-Verheij JCIY; Galjaard RJ; Henneman L;
    PLoS One; 2022; 17(5):e0267865. PubMed ID: 35499995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Women's Experience with Non-Invasive Prenatal Testing and Emotional Well-being and Satisfaction after Test-Results.
    van Schendel RV; Page-Christiaens GCML; Beulen L; Bilardo CM; de Boer MA; Coumans ABC; Faas BHW; van Langen IM; Lichtenbelt KD; van Maarle MC; Macville MVE; Oepkes D; Pajkrt E; Henneman L;
    J Genet Couns; 2017 Dec; 26(6):1348-1356. PubMed ID: 28667567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Routinization of prenatal screening with the non-invasive prenatal test: pregnant women's perspectives.
    van der Meij KRM; Njio A; Martin L; Gitsels-van der Wal JT; Bekker MN; van Vliet-Lachotzki EH; van der Ven AJEM; Kater-Kuipers A; Timmermans DRM; Sistermans EA; Galjaard RH; Henneman L;
    Eur J Hum Genet; 2022 Jun; 30(6):661-668. PubMed ID: 34385671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trial by Dutch laboratories for evaluation of non-invasive prenatal testing. Part II-women's perspectives.
    van Schendel RV; Page-Christiaens GC; Beulen L; Bilardo CM; de Boer MA; Coumans AB; Faas BH; van Langen IM; Lichtenbelt KD; van Maarle MC; Macville MV; Oepkes D; Pajkrt E; Henneman L;
    Prenat Diagn; 2016 Dec; 36(12):1091-1098. PubMed ID: 27739584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Women's Experiences and Preferences for Service Delivery of Non-Invasive Prenatal Testing for Aneuploidy in a Public Health Setting: A Mixed Methods Study.
    Lewis C; Hill M; Chitty LS
    PLoS One; 2016; 11(4):e0153147. PubMed ID: 27045195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survey of US obstetrician opinions regarding NIPT use in general practice: implementation and barriers.
    Brewer J; Demers L; Musci T
    J Matern Fetal Neonatal Med; 2017 Aug; 30(15):1793-1796. PubMed ID: 27588713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obstetric professionals' perceptions of non-invasive prenatal testing for Down syndrome: clinical usefulness compared with existing tests and ethical implications.
    Ngan OMY; Yi H; Wong SYS; Sahota D; Ahmed S
    BMC Pregnancy Childbirth; 2017 Sep; 17(1):285. PubMed ID: 28870159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex chromosome aneuploidy detection by noninvasive prenatal testing: helpful or hazardous?
    Reiss RE; Discenza M; Foster J; Dobson L; Wilkins-Haug L
    Prenat Diagn; 2017 May; 37(5):515-520. PubMed ID: 28326560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.